SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.
SMS Pharma filed its Business Responsibility and Sustainability Report for FY2025-26. Key initiatives include a new `1.9 Cr` CAPEX for advanced effluent treatment, commissioning a 1.3 MW rooftop solar project, and enhancing solvent recovery by 45-50%, significantly cutting hazardous waste. Local sourcing reduced transport-related GHG emissions by ~21 tCO2e.
CARE Ratings has reaffirmed SMS Pharma's Long Term Bank Facilities at 'CARE A'. The outlook for these facilities has been revised from Positive to Stable. Short Term Bank Facilities are also reaffirmed at 'CARE A1'. This action follows a review of the company's recent operational and financial performance. Total long-term...